© 2023 GeneDx All rights reserved.
January 26, 2023
GeneDx Announces Proposed Underwritten Public Offering of Class a Common Stock and Concurrent Registered Direct Offering
January 9, 2023
Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance
Displaying 11 - 12 of 12
